irasia.com - Investor Relations Asia Pacific
HOME

The United Laboratories International Holdings Limited
(Incorporated in the Cayman Islands with limited liability)

Press Releases       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2022-August-24
  • The United Laboratories International Holdings Limited Announces 2022 Interim Results, Ebitda up 8.0% to Rmb1,141 Million, Interim Dividend up 25.0% to RMB5 Cents Per Share, Sales Volume of Insulin Series Grows Steadily, Insulin Degludec/Insulin Aspart Injection Receive Clinical Trial Approval (in PDF)
  • 2022-March-24
  • The United Laboratories International Holdings Limited Announces 2021 Annual Results, Continuous Improvement in Profitability, Proposed Final Dividend and Special Dividend totaled RMB0.1 Per Share (in PDF)
  • 2021
  • 2021 Press Releases
  • 2020
  • 2020 Press Releases
  • 2019
  • 2019 Press Releases
  • 2018
  • 2018 Press Releases
  • 2017
  • 2017 Press Releases
  • 2016
  • 2016 Press Releases
  • 2015
  • 2015 Press Releases
  • 2014
  • 2014 Press Releases
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases
  • 2011
  • 2011 Press Releases
  • 2010
  • 2010 Press Releases
  • 2009
  • 2009 Press Releases
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2022 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.